Michael A. Fischer, MD, MS
Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
General Internal Medicine

MD, Yale University School of Medicine
MS, Harvard School of Public Health
AB, Harvard College

Pronouns: he/him/his



Michael Fischer, MD, MS is Chief of the Section of General Internal Medicine at Boston Medical Center/Chobanian and Avedisian School of Medicine. He is a primary care physician and health services researcher with expertise in developing and evaluating interventions to increase the use of evidence-based medical practices.

Dr. Fischer began his career at Brigham and Women’s Hospital, conducting research evaluating medication adherence; the appropriate use of prescription drugs; dissemination and implementation of evidence-based practices; prescription drug reimbursement policy; and the impact of electronic prescribing. He is the Director of the National Resource Center for Academic Detailing (www.NaRCAD.org), an initiative supported by the Agency for Health Care Research and Quality and the Centers for Disease Control and Prevention to assist organizations implementing interventions to improve health care quality and patient outcomes.

Diversity, Equity, Inclusion and Accessibility

Support for DEIA represents a core value for the Section of General Internal Medicine and in my own work. We are proud of the diversity embodied in our Section and in our commitment to equity, inclusion, and accessibility, but we all recognize that we must continue to work to enhance DEIA across the profession and the institution.

Within the Section, work on DEIA includes increasing transparency and ensuring equity of opportunity. We have initiated a new process for all available leadership positions, in collaboration with the Office of Equity, Vitality, and Inclusion. This will ensure that all leadership opportunities are posted and communicated and that applications, interviews, and decision-making about the positions occur with consistency. To support these efforts, we are gathering more complete data on the demographics of our faculty and staff, so that we can hold ourselves accountable for achieving these goals.

I currently serve as the co-sponsor for the BMC Equity Accelerator’s new initiative to promote equity in diabetes care and outcomes. Faculty and staff from our Section and across BMC are working with community partners to develop, implement, and evaluate interventions address the disparities in prevention, diagnosis, and treatment of diabetes.

Throughout my career I have mentored across differences with trainees and faculty, focusing on the ways in which I can provide support and serve as a champion for mentees and other colleagues.

Section Chief
Boston University Chobanian & Avedisian School of Medicine
Medicine
General Internal Medicine




BHEAT, Boston Hypertension Equity Alliance in Treatment: Comparing Team-Based Approaches to Hypertension Control in the Safety-Net Setting
10/01/2024 - 12/31/2030 (PI)
Patient-Centered Outcomes Research Institute (PCORI)

Boston Health Equity & community-Aligned Learning Health System (Boston-HEALHS)
01/01/2024 - 12/31/2027 (PI)
Agency for Healthcare Research and Quality/DHHS

THRIVE-DM: Improving Diabetes Care with Strategies for Addressing Health-Related Social Needs and Community Partnerships
08/12/2024 - 06/30/2026 (Multi-PI)
PI: Michael A. Fischer, MD, MS
National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
1R01DK140570-01

NaRCAD''s International Conference Series: An Innovative Model to Advance the Field of Clinical Outreach Education
09/30/2022 - 09/29/2025 (PI)
Agency for Healthcare Research and Quality/DHHS

Demonstrating, testing, and disseminating a sustainable model for academic detailing programs
10/01/2021 - 07/31/2025 (PI)
Agency for Healthcare Research and Quality/DHHS
5R18HS026177-06

Y4 Pilot 2: Refinement and adaptation of reinforcement learning to personalize behavioral messaging for healthy habits
08/15/2024 - 05/31/2025 (Subcontract PI)
PI: Michael A. Fischer, MD, MS
Massachusetts General Brigham NIH NIA
2P30AG064199-06

Y5 Project #2: Refinement and testing of recruitment methodology for behavioral medication adherence interventions using behavioral science-based approaches
08/15/2024 - 05/31/2025 (Subcontract PI)
PI: Michael A. Fischer, MD, MS
Massachusetts General Brigham NIH NIA
2P30AG064199-06

Y5 Project #2: Refinement and testing of recruitment methodology for behavioral medication adherence interventions using behavioral science-based approaches
06/01/2023 - 05/31/2025 (Subcontract PI)
PI: Michael A. Fischer, MD, MS
Brigham and Womens Hospital NIH NIA


Refinement and adaptation of reinforcement learning to personalize behavioral messaging for healthy habits
06/01/2022 - 05/31/2025 (Subcontract PI)
PI: Michael A. Fischer, MD, MS
Brigham and Womens Hospital NIH NIA
5P30AG064199-04

I kua na'u "Let Me Carry Out Your Last Wishes" Advance Care Planning for Native Hawaiian Elders
03/07/2023 - 02/28/2025 (Subcontract PI)
PI: Michael A. Fischer, MD, MS
Tufts Medical Center NIH NINR
7R01NR018400-04

Showing 10 of 14 results. Show All Results

Title


Yr Title Project-Sub Proj Pubs
2025 THRIVE-DM: Improving Diabetes Care with Strategies for Addressing Health-Related Social Needs and Community Partnerships 5R01DK140570-02
2025 Administrative Core (AC) 5P30HS029752-02-7503
2025 Boston Health Equity & community-Aligned Learning Health System (Boston-HEALHS) 5P30HS029752-02
2024 THRIVE-DM: Improving Diabetes Care with Strategies for Addressing Health-Related Social Needs and Community Partnerships 1R01DK140570-01
2024 Boston Health Equity & community-Aligned Learning Health System (Boston-HEALHS) 1P30HS029752-01
2024 Administrative Core (AC) 1P30HS029752-01-7503
2024 NaRCAD's International Conference Series: An Innovative Model to Advance the Field of Clinical Outreach Education 5R13HS028936-03
2023 NaRCAD's International Conference Series: An Innovative Model to Advance the Field of Clinical Outreach Education 5R13HS028936-02
2023 Demonstrating, testing, and disseminating a sustainable model for academic detailing programs 5R18HS026177-06
2022 Demonstrating, testing, and disseminating a sustainable model for academic detailing programs 5R18HS026177-05
Showing 10 of 37 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Miyawaki A, Ladines-Lim JB, Sato D, Kitajima K, Linder JA, Fischer MA, Chua KP, Tsugawa Y. Association of patient, physician and visit characteristics with inappropriate antibiotic prescribing in Japanese primary care: a cross-sectional study. BMJ Public Health. 2025; 3(2):e002364. PMID: 40842720; PMCID: PMC12366620; DOI: 10.1136/bmjph-2024-002364;
     
  2. Brown T, Guzman A, Lee JY, Fischer MA, Friedberg MW, Linder JA. Clinicians' Reasons for Non-Visit-Based, No-Infectious-Diagnosis-Documented Antibiotic Prescribing: A Sequential Mixed-Methods Study. Antibiotics (Basel). 2025 Jul 23; 14(8). PMID: 40867935; PMCID: PMC12382833; DOI: 10.3390/antibiotics14080740;
     
  3. Vasic V, Dickopf S, Spranger N, Rosenberger RS, Fischer M, Mayer K, Larraillet V, Bates JA, Maier V, Sela T, Nussbaum B, Duerr H, Dengl S, Brinkmann U. Generation of binder-format-payload conjugate-matrices by antibody chain-exchange. Nat Commun. 2024 Oct 31; 15(1):9406. PMID: 39477939; PMCID: PMC11525586; DOI: 10.1038/s41467-024-53730-3;
     
  4. Chua KP, Fischer MA, Rahman M, Linder JA. Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the COVID-19 Outbreak: An Interrupted Time Series Analysis of 2016-2021 Data. Clin Infect Dis. 2024 Aug 16; 79(2):312-320. PMID: 38648159; PMCID: PMC11327783; DOI: 10.1093/cid/ciae135;
     
  5. Ladines-Lim JB, Fischer MA, Linder JA, Chua KP. Appropriateness of Antibiotic Prescribing in US Emergency Department Visits, 2016-2021. Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e79. PMID: 38751940; PMCID: PMC11094377; DOI: 10.1017/ash.2024.79;
     
  6. Briem T, Stephan A, Stadelmann VA, Fischer MA, Pfirrmann CWA, Rüdiger HA, Leunig M. Mid-term results of autologous matrix-induced chondrogenesis for large chondral defects in hips with femoroacetabular impingement syndrome. Bone Joint J. 2024 May 01; 106-B(5 Supple B):32-39. PMID: 38688500
     
  7. Ladines-Lim JB, Fischer MA, Linder JA, Chua KP. Prevalence of Inappropriate Antibiotic Prescribing with or without a Plausible Antibiotic Indication among Safety-Net and Non-Safety Net Populations. J Gen Intern Med. 2024 Jul; 39(9):1606-1615. PMID: 38671203; PMCID: PMC11255153; DOI: 10.1007/s11606-024-08757-z;
     
  8. Cromer SJ, Steiner B, York C, Mastrorilli J, Lake GA, Leibowitz S, Simmons L, Steppel-Reznik J, Low G, Fischer MA, Patorno E, Wexler DJ. Successful implementation of a stakeholder engagement program for pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. 2024 Jan; 33(1):e5727. PMID: 37985010; PMCID: PMC10841974; DOI: 10.1002/pds.5727;
     
  9. Brown T, Lee JY, Guzman A, Fischer MA, Friedberg MW, Chua KP, Linder JA. Prevalence and appropriateness of in-person versus not-in-person ambulatory antibiotic prescribing in an integrated academic health system: A cohort study. PLoS One. 2023; 18(7):e0289303. PMID: 37498818; PMCID: PMC10374053; DOI: 10.1371/journal.pone.0289303;
     
  10. Hendricks MA, El Ibrahimi S, Ritter GA, Flores D, Fischer MA, Weiss RD, Wright DA, Weiner SG. Association of Household Opioid Availability With Opioid Overdose. JAMA Netw Open. 2023 Mar 01; 6(3):e233385. PMID: 36930154; PMCID: PMC10024199; DOI: 10.1001/jamanetworkopen.2023.3385;
     
Showing 10 of 182 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 182 publications over 26 distinct years, with a maximum of 13 publications in 2022

YearPublications
19911
19951
20021
20032
20044
20054
20067
20078
20085
20092
201012
20117
20129
20139
201412
201512
201610
20179
201810
201911
202011
202112
202213
20233
20245
20252

2012 National Association of Chain Drug Stores Foundation: Excellence in Patient Care and Research Award
2006 Blue Cross Blue Shield of Massachusetts: Excellence in Primary Care Honoree
2002 BWH, Boston, MA: Partners in Excellence Award: Leadership and Innovation
1997 Yale University School of Medicine, New Haven CT: Alpha Omega Alpha
1997 Yale University School of Medicine, New Haven CT: John P. Peters Prize for Outstanding Thesis
1997 Yale University School of Medicine, New Haven CT: Farr Scholar
1992 Harvard College, Boston, MA: Magna Cum Laude
1988 Harvard College, Boston, MA: Harvard National Scholar
Contact for Mentoring:

801 Massachusetts Ave
Boston MA 02118
Google Map


Fischer's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department